Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway
Authors
Keywords
-
Journal
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
Volume 36, Issue 2, Pages 213-219
Publisher
Informa UK Limited
Online
2015-10-14
DOI
10.3109/10799893.2015.1075041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulation of vitamin D signaling is a potential therapeutic target to lower cardiovascular risk in chronic kidney disease
- (2013) Peng Hu et al. MEDICAL SCIENCE MONITOR
- Genotype-Phenotype Correlation of 2q37 Deletions Including NPPC Gene Associated with Skeletal Malformations
- (2013) Elisa Tassano et al. PLoS One
- Bidirectional communication between oocytes and ovarian follicular somatic cells is required for meiotic arrest of mammalian oocytes
- (2013) K. Wigglesworth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study
- (2013) Abeer Yasin et al. BMC Nephrology
- Epidemiological study of orthopedic injuries in hemodialysis patients in Taiwan: a fixed cohort survey, 2004–2008
- (2013) Nien-Tzu Chang et al. Clinical Interventions in Aging
- Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia
- (2012) Florence Lorget et al. AMERICAN JOURNAL OF HUMAN GENETICS
- FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2–SGK1 signaling pathway
- (2012) Olena Andrukhova et al. BONE
- Skeletal Analysis of the Long Bone Abnormality (lbab/lbab) Mouse, A Novel Chondrodysplastic C-Type Natriuretic Peptide Mutant
- (2012) Eri Kondo et al. CALCIFIED TISSUE INTERNATIONAL
- Fibroblast Growth Factor-23 Helps Explain the Biphasic Cardiovascular Effects of Vitamin D in Chronic Kidney Disease
- (2012) Peng Hu et al. International Journal of Biological Sciences
- p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice
- (2012) Yingli Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Osteoporosis and adynamic bone in chronic kidney disease
- (2012) Jorge B. Cannata-Andía et al. JOURNAL OF NEPHROLOGY
- Overexpressed C-type natriuretic peptide serves as an early compensatory response to counteract extracellular matrix remodeling in unilateral ureteral obstruction rats
- (2012) Peng Hu et al. MOLECULAR BIOLOGY REPORTS
- Increased urinary C-type natriuretic peptide excretion may be an early marker of renal tubulointerstitial fibrosis
- (2012) Peng Hu et al. PEPTIDES
- An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 Gene
- (2012) Kohji Miura et al. PLoS One
- Interleukin-1β, tumour necrosis factor-α and lipopolysaccharide induce C-type natriuretic peptide from canine aortic endothelial cells
- (2012) Kara Osterbur et al. RESEARCH IN VETERINARY SCIENCE
- Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients
- (2012) Eiichiro Kanda et al. BMC Nephrology
- Inhibition of Pathological Differentiation of Valvular Interstitial Cells by C-Type Natriuretic Peptide
- (2011) Cindy Y.Y. Yip et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Early Skeletal and Biochemical Alterations in Pediatric Chronic Kidney Disease
- (2011) K. Wesseling-Perry et al. Clinical Journal of the American Society of Nephrology
- C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target
- (2011) Natalie G. Lumsden et al. CURRENT PHARMACEUTICAL DESIGN
- Sixteen years and counting: The current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias
- (2011) Silvie Foldynova-Trantirkova et al. HUMAN MUTATION
- Endogenous vascular synthesis of B-type and C-type natriuretic peptides in the rainbow trout
- (2011) K. R. Johnson et al. JOURNAL OF EXPERIMENTAL BIOLOGY
- Differences in Bone Quality in Low- and High-Turnover Renal Osteodystrophy
- (2011) H. H. Malluche et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Phosphorous Dysregulation Induced by MEK Small Molecule Inhibitors in the Rat Involves Blockade of FGF-23 Signaling in the Kidney
- (2011) Dolores Diaz et al. TOXICOLOGICAL SCIENCES
- Transforming growth factor-β1 regulation of C-type natriuretic peptide expression in human vascular smooth muscle cells: dependence on TSC22D1
- (2010) Maria C. Mendonça et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Value of the New Bone Classification System in Pediatric Renal Osteodystrophy
- (2010) S. A. Bakkaloglu et al. Clinical Journal of the American Society of Nephrology
- Achondroplasia: pathogenesis and implications for future treatment
- (2010) Melanie B Laederich et al. CURRENT OPINION IN PEDIATRICS
- Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias
- (2010) Akihiro Yasoda et al. ENDOCRINE JOURNAL
- Circulating C-Type Natriuretic Peptide (CNP) Rescues Chondrodysplastic CNP Knockout Mice from Their Impaired Skeletal Growth and Early Death
- (2010) Toshihito Fujii et al. ENDOCRINOLOGY
- The Aging Heart, Myocardial Fibrosis, and its Relationship to Circulating C-Type Natriuretic Peptide
- (2010) S. Jeson Sangaralingham et al. HYPERTENSION
- Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men
- (2010) Majd AI Mirza et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patients
- (2010) Hartmut H Malluche et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Influence of Glomerular Filtration Rate and Age on Fibroblast Growth Factor 23 Serum Levels in Pediatric Chronic Kidney Disease
- (2010) Justine Bacchetta et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cyclic GMP and Protein Kinase G Control a Src-Containing Mechanosome in Osteoblasts
- (2010) H. Rangaswami et al. Science Signaling
- Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease
- (2009) Renata C. Pereira et al. BONE
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure
- (2009) Paul R. Kalra et al. CLINICAL SCIENCE
- Increased Bone Volume and Correction of HYP Mouse Hypophosphatemia in the Klotho/HYP Mouse
- (2009) Catherine A. Brownstein et al. ENDOCRINOLOGY
- Regional Release and Clearance of C-Type Natriuretic Peptides in the Human Circulation and Relation to Cardiac Function
- (2009) Suetonia C. Palmer et al. HYPERTENSION
- Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia*
- (2009) Yukiko Aono et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active
- (2009) Takashi Shimada et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients
- (2009) Hirotaka Komaba et al. KIDNEY INTERNATIONAL
- New Insight on FGFR3-Related Chondrodysplasias Molecular Physiopathology Revealed by Human Chondrocyte Gene Expression Profiling
- (2009) Laurent Schibler et al. PLoS One
- Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Bone Mineralization in Children with Renal Failure on Peritoneal Dialysis
- (2008) Katherine Wesseling-Perry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGFR3 and FGFR4 Do not Mediate Renal Effects of FGF23
- (2008) S. Liu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab−/− mice
- (2008) Andrea R. Yoder et al. PEPTIDES
- C-type natriuretic peptide and endothelium-dependent hyperpolarization in the guinea-pig carotid artery
- (2007) V Leuranguer et al. BRITISH JOURNAL OF PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started